XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation of the U.S. Statutory Income Tax Rate to the Company's Effective Tax Rate
A reconciliation of the U.S. statutory income tax rate to the Company’s effective tax rate is as follows:
December 31,
20232022
Federal income tax (benefit) at statutory rate(21.0)%(21.0)%
Change in state tax rate0.2 %(0.5)%
Permanent items0.2 %0.1 %
Prior period adjustments0.9 %(3.6)%
Change in valuation allowance19.7 %25.0 %
Effective income tax rate0.0 %0.0 %
Summary of Income Tax Contingencies
December 31,
20232022
(in thousands)
Balance at January 1$2,099 $2,099 
Reductions for tax positions of prior year— — 
Balance at December 312,099 2,099 
Schedule of Significant Components of the Company's Deferred Tax Assets
Significant components of the Company’s deferred tax assets are summarized in the table below:
December 31,
20232022
(in thousands)
Deferred tax assets:
Federal and state operating loss carryforwards$258,836 $242,584 
Equity compensation25,413 26,243 
Capitalized research and development37,998 26,480 
R&D tax credits, net of reserves18,887 18,887 
Disallowed interest43,239 29,979 
Temporary differences12,362 8,340 
Total deferred tax assets396,735 352,513 
Deferred tax liabilities:
Other(1,154)(400)
Total deferred tax liabilities(1,154)(400)
Valuation allowance(395,581)(352,113)
Net deferred tax assets$— $—